IRS Releases Comprehensive Guidance on Various SECURE 2.0 Provisions
On Dec. 20, 2023, the IRS issued Notice 2024-2, providing guidance in the form of questions and...
Joint Agency Guidance on Gag Clause Prohibition for Health Plan Agreement
On February 23, 2023, the Department of Labor (DOL), the Department of Health and Human Services...
Health Plans Must Submit Gag Clause Attestations by Dec. 31, 2023
On Feb. 23, 2023, the Departments of Labor, Health and Human Services and the Treasury...
Continuing Appropriations Act Extends HDHP Relief for Telehealth Services
President Biden last week signed the Continuing Appropriations Act, 2023 (CAA 23) to provide...
"SECURE 2.0" Becomes Law
On Dec. 29, 2022, President Biden signed the Consolidated Appropriations Act of 2023, an omnibus...
December 27 Due Date for Prescription Drug Cost Reporting is Approaching
As part of the Consolidated Appropriations Act of 2021 (CAA), group health plans and carriers...
Price Comparison Tool Required for 2023 Plan Years
Effective for plan years beginning on or after Jan. 1, 2023, group health plans and health...
Departments Issue Final Rules to Clarify Dispute Resolution and Transparency under the No Surprises Act
On August 19, the U.S. Departments of Health and Human Services, Labor, and the Treasury (the...
Broker Compensation Transparency Requirements
Signed into law in late 2020, the Consolidated Appropriations Act, 2021 (CAA) created new...
Health Care Transparency and No Surprises Act Requirements | Employer Compliance Summary
Group health plans and health insurance issuers are subject to many new requirements designed to...
No Surprises Act: Transparency Reporting Pharmacy & Drug Costs
The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA),...
